Skip to content

Author

S. Samodelov

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Re-evaluating variability of circulating miR-122 in healthy volunteers: Implications for biomarker qualification in drug-induced liver injury.

Drug-induced liver injury (DILI) remains a major challenge in clinical practice and drug development, and reliable biomarkers are still needed. MicroRNA-122 (miR-122) has shown promise, but reported inter-individual variability in healthy populations has raised concerns about its clinical utility. We analysed circulati...

Irum Javid, G. Russomanno, Anthony Evans et al. · 0 citations
Open access Aug 2026

Enzalutamide-Induced Host Metabolic Reprogramming Is Associated with Treatment Outcomes in Patients with Castration-Resistant Prostate Cancer: A Hypothesis-Generating Study.

Host metabolic changes in response to drug treatment may shape individual pharmacological outcomes. This study aims to identify serum metabolomics signatures potentially associated with individual responses to enzalutamide treatment in metastatic castrate-resistant prostate cancer (mCRPC) patients. Targeted metabolomic...

Giuseppe Corona, M. Visentin, S. Samodelov et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.